EU/3/04/191: Orphan designation for the treatment of congenital venous malformations


Table of contents


Please note that this product was withdrawn from the Community Register of designated Orphan Medicinal Products in July 2015 on request of the sponsor.

On 8 March 2004, orphan designation (EU/3/04/191) was granted by the European Commission to Orfagen, France, for ethanol (96 per cent) (gel for injection) for the treatment of congenital venous malformations.

Key facts

Active substance
Intended use
Treatment of congenital venous malformations
Orphan designation status
EU designation number
Date of designation
CRDPF Langlade
3 Avenue Hubert Curien - BP 13562
31035 Toulouse Cedex 1
Tel. +33 5345 06459
Fax +33 5345 03457

Documents related to this orphan designation evaluation

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

EU register of orphan medicines

The list of medicines that have received an orphan designation in the EU is available on the European Commission's website:

How useful was this page?

Add your rating